(2S,4R)-1-[(2S)-2-[7-[[6-cyclopropyl-4-[(1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-7-(6-fluoro-5-methyl-1H-indazol-4-yl)-2-(oxan-4-yloxy)quinazolin-8-yl]oxymethyl]-4-oxo-5H-pyrazolo[3,4-c]quinolin-2-yl]-3-methylbutanoyl]-N-[[4-(2-ethylpyrazol-3-yl)-2-(1-methylpiperidin-4-yl)oxyphenyl]methyl]-4-hydroxypyrrolidine-2-carboxamide

C68H77FN14O8 — CID 176976970

IUPAC(2S,4R)-1-[(2S)-2-[7-[[6-cyclopropyl-4-[(1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-7-(6-fluoro-5-methyl-1H-indazol-4-yl)-2-(oxan-4-yloxy)quinazolin-8-yl]oxymethyl]-4-oxo-5H-pyrazolo[3,4-c]quinolin-2-yl]-3-methylbutanoyl]-N-[[4-(2-ethylpyrazol-3-yl)-2-(1-methylpiperidin-4-yl)oxyphenyl]methyl]-4-hydroxypyrrolidine-2-carboxamide
SMILESCCn1nccc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H](C(C)C)n2cc3c(n2)c(=O)[nH]c2cc(COc4c(-c5c(C)c(F)cc6[nH]ncc56)c(C5CC5)cc5c(N6C[C@@H]7C[C@H]6CN7)nc(OC6CCOCC6)nc45)ccc23)c(OC2CCN(C)CC2)c1
InChIInChI=1S/C68H77FN14O8/c1-6-82-55(13-18-73-82)40-10-11-41(57(24-40)90-45-14-19-79(5)20-15-45)29-71-65(85)56-26-44(84)33-81(56)67(87)62(36(2)3)83-34-51-47-12-7-38(23-53(47)74-66(86)61(51)78-83)35-89-63-59(58-37(4)52(69)28-54-50(58)31-72-77-54)48(39-8-9-39)27-49-60(63)75-68(91-46-16-21-88-22-17-46)76-64(49)80-32-42-25-43(80)30-70-42/h7,10-13,18,23-24,27-28,31,34,36,39,42-46,56,62,70,84H,6,8-9,14-17,19-22,25-26,29-30,32-33,35H2,1-5H3,(H,71,85)(H,72,77)(H,74,86)/t42-,43-,44+,56-,62-/m0/s1
InChIKeyRBSNJJWYIRECCJ-OJCZQSJPSA-N
MW1237.45 g/mol
LogP8.21
Rot. Bonds18

About (2S,4R)-1-[(2S)-2-[7-[[6-cyclopropyl-4-[(1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-7-(6-fluoro-5-methyl-1H-indazol-4-yl)-2-(oxan-4-yloxy)quinazolin-8-yl]oxymethyl]-4-oxo-5H-pyrazolo[3,4-c]quinolin-2-yl]-3-methylbutanoyl]-N-[[4-(2-ethylpyrazol-3-yl)-2-(1-methylpiperidin-4-yl)oxyphenyl]methyl]-4-hydroxypyrrolidine-2-carboxamide

(2S,4R)-1-[(2S)-2-[7-[[6-cyclopropyl-4-[(1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-7-(6-fluoro-5-methyl-1H-indazol-4-yl)-2-(oxan-4-yloxy)quinazolin-8-yl]oxymethyl]-4-oxo-5H-pyrazolo[3,4-c]quinolin-2-yl]-3-methylbutanoyl]-N-[[4-(2-ethylpyrazol-3-yl)-2-(1-methylpiperidin-4-yl)oxyphenyl]methyl]-4-hydroxypyrrolidine-2-carboxamide (PubChem CID 176976970) has the molecular formula C68H77FN14O8 and a molecular weight of 1237.45 g/mol. Its IUPAC name is (2S,4R)-1-[(2S)-2-[7-[[6-cyclopropyl-4-[(1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-7-(6-fluoro-5-methyl-1H-indazol-4-yl)-2-(oxan-4-yloxy)quinazolin-8-yl]oxymethyl]-4-oxo-5H-pyrazolo[3,4-c]quinolin-2-yl]-3-methylbutanoyl]-N-[[4-(2-ethylpyrazol-3-yl)-2-(1-methylpiperidin-4-yl)oxyphenyl]methyl]-4-hydroxypyrrolidine-2-carboxamide.

Molecular Properties

Compound Name(2S,4R)-1-[(2S)-2-[7-[[6-cyclopropyl-4-[(1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-7-(6-fluoro-5-methyl-1H-indazol-4-yl)-2-(oxan-4-yloxy)quinazolin-8-yl]oxymethyl]-4-oxo-5H-pyrazolo[3,4-c]quinolin-2-yl]-3-methylbutanoyl]-N-[[4-(2-ethylpyrazol-3-yl)-2-(1-methylpiperidin-4-yl)oxyphenyl]methyl]-4-hydroxypyrrolidine-2-carboxamide
PubChem CID176976970
Molecular FormulaC68H77FN14O8
Molecular Weight1237.45 g/mol
Exact Mass1236.60
IUPAC Name(2S,4R)-1-[(2S)-2-[7-[[6-cyclopropyl-4-[(1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-7-(6-fluoro-5-methyl-1H-indazol-4-yl)-2-(oxan-4-yloxy)quinazolin-8-yl]oxymethyl]-4-oxo-5H-pyrazolo[3,4-c]quinolin-2-yl]-3-methylbutanoyl]-N-[[4-(2-ethylpyrazol-3-yl)-2-(1-methylpiperidin-4-yl)oxyphenyl]methyl]-4-hydroxypyrrolidine-2-carboxamide
SMILESCCn1nccc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H](C(C)C)n2cc3c(n2)c(=O)[nH]c2cc(COc4c(-c5c(C)c(F)cc6[nH]ncc56)c(C5CC5)cc5c(N6C[C@@H]7C[C@H]6CN7)nc(OC6CCOCC6)nc45)ccc23)c(OC2CCN(C)CC2)c1
InChIInChI=1S/C68H77FN14O8/c1-6-82-55(13-18-73-82)40-10-11-41(57(24-40)90-45-14-19-79(5)20-15-45)29-71-65(85)56-26-44(84)33-81(56)67(87)62(36(2)3)83-34-51-47-12-7-38(23-53(47)74-66(86)61(51)78-83)35-89-63-59(58-37(4)52(69)28-54-50(58)31-72-77-54)48(39-8-9-39)27-49-60(63)75-68(91-46-16-21-88-22-17-46)76-64(49)80-32-42-25-43(80)30-70-42/h7,10-13,18,23-24,27-28,31,34,36,39,42-46,56,62,70,84H,6,8-9,14-17,19-22,25-26,29-30,32-33,35H2,1-5H3,(H,71,85)(H,72,77)(H,74,86)/t42-,43-,44+,56-,62-/m0/s1
InChIKeyRBSNJJWYIRECCJ-OJCZQSJPSA-N
XLogP8.21
TPSA248.03 Ų
H-Bond Donors5
H-Bond Acceptors18
Rotatable Bonds18
Heavy Atoms91
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001237.45
LogP ≤ 58.21
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1018

Analyze (2S,4R)-1-[(2S)-2-[7-[[6-cyclopropyl-4-[(1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-7-(6-fluoro-5-methyl-1H-indazol-4-yl)-2-(oxan-4-yloxy)quinazolin-8-yl]oxymethyl]-4-oxo-5H-pyrazolo[3,4-c]quinolin-2-yl]-3-methylbutanoyl]-N-[[4-(2-ethylpyrazol-3-yl)-2-(1-methylpiperidin-4-yl)oxyphenyl]methyl]-4-hydroxypyrrolidine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2S,4R)-1-[(2S)-2-[7-[[6-cyclopropyl-4-[(1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-7-(6-fluoro-5-methyl-1H-indazol-4-yl)-2-(oxan-4-yloxy)quinazolin-8-yl]oxymethyl]-4-oxo-5H-pyrazolo[3,4-c]quinolin-2-yl]-3-methylbutanoyl]-N-[[4-(2-ethylpyrazol-3-yl)-2-(1-methylpiperidin-4-yl)oxyphenyl]methyl]-4-hydroxypyrrolidine-2-carboxamide?
The IUPAC name of (2S,4R)-1-[(2S)-2-[7-[[6-cyclopropyl-4-[(1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-7-(6-fluoro-5-methyl-1H-indazol-4-yl)-2-(oxan-4-yloxy)quinazolin-8-yl]oxymethyl]-4-oxo-5H-pyrazolo[3,4-c]quinolin-2-yl]-3-methylbutanoyl]-N-[[4-(2-ethylpyrazol-3-yl)-2-(1-methylpiperidin-4-yl)oxyphenyl]methyl]-4-hydroxypyrrolidine-2-carboxamide (CID 176976970) is (2S,4R)-1-[(2S)-2-[7-[[6-cyclopropyl-4-[(1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-7-(6-fluoro-5-methyl-1H-indazol-4-yl)-2-(oxan-4-yloxy)quinazolin-8-yl]oxymethyl]-4-oxo-5H-pyrazolo[3,4-c]quinolin-2-yl]-3-methylbutanoyl]-N-[[4-(2-ethylpyrazol-3-yl)-2-(1-methylpiperidin-4-yl)oxyphenyl]methyl]-4-hydroxypyrrolidine-2-carboxamide.
What is the SMILES notation for (2S,4R)-1-[(2S)-2-[7-[[6-cyclopropyl-4-[(1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-7-(6-fluoro-5-methyl-1H-indazol-4-yl)-2-(oxan-4-yloxy)quinazolin-8-yl]oxymethyl]-4-oxo-5H-pyrazolo[3,4-c]quinolin-2-yl]-3-methylbutanoyl]-N-[[4-(2-ethylpyrazol-3-yl)-2-(1-methylpiperidin-4-yl)oxyphenyl]methyl]-4-hydroxypyrrolidine-2-carboxamide?
The canonical SMILES for (2S,4R)-1-[(2S)-2-[7-[[6-cyclopropyl-4-[(1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-7-(6-fluoro-5-methyl-1H-indazol-4-yl)-2-(oxan-4-yloxy)quinazolin-8-yl]oxymethyl]-4-oxo-5H-pyrazolo[3,4-c]quinolin-2-yl]-3-methylbutanoyl]-N-[[4-(2-ethylpyrazol-3-yl)-2-(1-methylpiperidin-4-yl)oxyphenyl]methyl]-4-hydroxypyrrolidine-2-carboxamide is CCn1nccc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H](C(C)C)n2cc3c(n2)c(=O)[nH]c2cc(COc4c(-c5c(C)c(F)cc6[nH]ncc56)c(C5CC5)cc5c(N6C[C@@H]7C[C@H]6CN7)nc(OC6CCOCC6)nc45)ccc23)c(OC2CCN(C)CC2)c1.
What is the InChIKey of (2S,4R)-1-[(2S)-2-[7-[[6-cyclopropyl-4-[(1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-7-(6-fluoro-5-methyl-1H-indazol-4-yl)-2-(oxan-4-yloxy)quinazolin-8-yl]oxymethyl]-4-oxo-5H-pyrazolo[3,4-c]quinolin-2-yl]-3-methylbutanoyl]-N-[[4-(2-ethylpyrazol-3-yl)-2-(1-methylpiperidin-4-yl)oxyphenyl]methyl]-4-hydroxypyrrolidine-2-carboxamide?
The InChIKey is RBSNJJWYIRECCJ-OJCZQSJPSA-N. The full InChI is InChI=1S/C68H77FN14O8/c1-6-82-55(13-18-73-82)40-10-11-41(57(24-40)90-45-14-19-79(5)20-15-45)29-71-65(85)56-26-44(84)33-81(56)67(87)62(36(2)3)83-34-51-47-12-7-38(23-53(47)74-66(86)61(51)78-83)35-89-63-59(58-37(4)52(69)28-54-50(58)31-72-77-54)48(39-8-9-39)27-49-60(63)75-68(91-46-16-21-88-22-17-46)76-64(49)80-32-42-25-43(80)30-70-42/h7,10-13,18,23-24,27-28,31,34,36,39,42-46,56,62,70,84H,6,8-9,14-17,19-22,25-26,29-30,32-33,35H2,1-5H3,(H,71,85)(H,72,77)(H,74,86)/t42-,43-,44+,56-,62-/m0/s1.
What are the key properties of (2S,4R)-1-[(2S)-2-[7-[[6-cyclopropyl-4-[(1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-7-(6-fluoro-5-methyl-1H-indazol-4-yl)-2-(oxan-4-yloxy)quinazolin-8-yl]oxymethyl]-4-oxo-5H-pyrazolo[3,4-c]quinolin-2-yl]-3-methylbutanoyl]-N-[[4-(2-ethylpyrazol-3-yl)-2-(1-methylpiperidin-4-yl)oxyphenyl]methyl]-4-hydroxypyrrolidine-2-carboxamide?
(2S,4R)-1-[(2S)-2-[7-[[6-cyclopropyl-4-[(1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-7-(6-fluoro-5-methyl-1H-indazol-4-yl)-2-(oxan-4-yloxy)quinazolin-8-yl]oxymethyl]-4-oxo-5H-pyrazolo[3,4-c]quinolin-2-yl]-3-methylbutanoyl]-N-[[4-(2-ethylpyrazol-3-yl)-2-(1-methylpiperidin-4-yl)oxyphenyl]methyl]-4-hydroxypyrrolidine-2-carboxamide has a molecular weight of 1237.45 g/mol, XLogP of 8.21, 18 rotatable bonds, 5 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for (2S,4R)-1-[(2S)-2-[7-[[6-cyclopropyl-4-[(1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-7-(6-fluoro-5-methyl-1H-indazol-4-yl)-2-(oxan-4-yloxy)quinazolin-8-yl]oxymethyl]-4-oxo-5H-pyrazolo[3,4-c]quinolin-2-yl]-3-methylbutanoyl]-N-[[4-(2-ethylpyrazol-3-yl)-2-(1-methylpiperidin-4-yl)oxyphenyl]methyl]-4-hydroxypyrrolidine-2-carboxamide is sourced from PubChem (CID 176976970), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).